Synuclav 200 mg/50 mg Tablets for Dogs

None.

Special precautions for safe use in the target species:
Inappropriate use of the product may increase the prevalence of bacteria resistant to
amoxicillin/clavulanic acid.
In animals with hepatic and renal failure, the dosing regimen should be carefully
evaluated.
Use of the product should be based on susceptibility testing and take into account
official and local antimicrobial policies. Narrow spectrum antibacterial therapy should
be used for first line treatment where susceptibility testing suggests likely efficacy of
this approach.
Caution is advised in the use in small herbivores other than those in 3.3.
Dogs and cats diagnosed with Pseudomonas infections should not be treated with this
antibiotic combination.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection,
inhalation, ingestion, or skin contact. Hypersensitivity to penicillins may lead to cross-
reactions to cephalosporins and vice versa. Allergic reactions to these substances
may occasionally be serious.
Do not handle this veterinary medicinal product if you know you are sensitised, or if
you have been advised not to work with such preparations.
AN: 00657/2025 & 00662/2025
Handle this veterinary medicinal product with great care to avoid exposure, taking all
recommended precautions.
If you develop symptoms following exposure such as a skin rash, you should seek
medical advice and show the package leaflet or the label to the physician. Swelling of
the face, lips or eyes or difficulty with breathing are more serious symptoms and
require urgent medical attention.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.